Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A

Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A

Source: 
Fierce Biotech
snippet: 

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that could reach up to $1 billion in biobucks.